Annual Meeting Highlights

ASH 2014: Highlights in HL
ASH 2014: Highlights in Hodgkin Lymphoma
View expert discussions regarding exciting news focusing on HL from the 2014 American Society of Hematology meeting. Follow-up analysis of the HD2000 trial, results from the AETHERA trial, and a study of the combination of brentuximab vedotin with bendamustine in relapsed or refractory patients are covered.


View 

EHA 2014 Highlights
EHA 2014: Highlights in Hodgkin Lymphoma
Video highlights from the 19th European Hematology Association Congress in Milan, Italy by world-renowned experts on clinical trial findings and the potential implications of key study findings in Hodgkin lymphoma are presented.


View 

9th ISHL Highlights
9th ISHL Highlights
Welcome to video highlights and written abstracts of the 9th International Symposium of Hodgkin Lymphoma in Cologne, Germany. Join world-renowned experts as they discuss clinical trial findings and the potential implications of key study findings for community practice.


View 

12th ICML Highlights in Lymphoma
12th ICML Highlights in Lymphoma

Clinical experts discuss key findings relative to new and emerging treatments for Hodgkin lymphoma.

Provided by MediCom Worldwide, Inc.
Supported by an educational grant from Millennium: The Takeda Oncology Company

View 
Last modified: December 16, 2014

Managing HL would like to recognize and thank Merck & Co., Inc., Seattle Genetics, and Takeda Oncology for their educational support of ManagingHodgkinLymphoma.com

©2017 MediCom Worldwide, Inc. All rights reserved